Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. j. med. biol. res ; 47(6): 461-469, 06/2014. graf
Artículo en Inglés | LILACS | ID: lil-709449

RESUMEN

A previous study showed that BMP-2 (bone morphogenetic protein-2) and wear debris can separately support osteoclast formation induced by the receptor activator of NF-κB ligand (RANKL). However, the effect of BMP-2 on wear debris-induced osteoclast formation is unclear. In this study, we show that neither titanium particles nor BMP-2 can induce osteoclast formation in RAW 264.7 mouse leukemic monocyte macrophage cells but that BMP-2 synergizes with titanium particles to enhance osteoclast formation in the presence of RANKL, and that at a low concentration, BMP-2 has an optimal effect to stimulate the size and number of multinuclear osteoclasts, expression of osteoclast genes, and resorption area. Our data also clarify that the effects caused by the increase in BMP-2 on phosphorylated SMAD levels such as c-Fos expression increased throughout the early stages of osteoclastogenesis. BMP-2 and titanium particles stimulate the expression of p-JNK, p-P38, p-IkB, and P50 compared with the titanium group. These data suggested that BMP-2 may be a crucial factor in titanium particle-mediated osteoclast formation.


Asunto(s)
Animales , Ratones , /farmacología , Diferenciación Celular/efectos de los fármacos , Macrófagos/efectos de los fármacos , Osteoclastos/metabolismo , Ligando RANK/farmacología , Titanio/farmacología , Fosfatasa Ácida/farmacología , Western Blotting , Resorción Ósea/metabolismo , Línea Celular Tumoral , Supervivencia Celular , Sinergismo Farmacológico , Ensayo de Inmunoadsorción Enzimática , Expresión Génica , Isoenzimas/farmacología , Reacción en Cadena en Tiempo Real de la Polimerasa , Proteínas Smad/metabolismo , Factor de Necrosis Tumoral alfa/aislamiento & purificación
2.
Braz. j. med. biol. res ; 46(10): 831-838, 24/set. 2013. tab, graf
Artículo en Inglés | LILACS | ID: lil-688557

RESUMEN

Wear particles are phagocytosed by macrophages and other inflammatory cells, resulting in cellular activation and release of proinflammatory factors, which cause periprosthetic osteolysis and subsequent aseptic loosening, the most common causes of total joint arthroplasty failure. During this pathological process, tumor necrosis factor-alpha (TNF-α) plays an important role in wear-particle-induced osteolysis. In this study, recombination adenovirus (Ad) vectors carrying both target genes [TNF-α small interfering RNA (TNF-α-siRNA) and bone morphogenetic protein 2 (BMP-2)] were synthesized and transfected into RAW264.7 macrophages and pro-osteoblastic MC3T3-E1 cells, respectively. The target gene BMP-2, expressed on pro-osteoblastic MC3T3-E1 cells and silenced by the TNF-α gene on cells, was treated with titanium (Ti) particles that were assessed by real-time PCR and Western blot. We showed that recombinant adenovirus (Ad-siTNFα-BMP-2) can induce osteoblast differentiation when treated with conditioned medium (CM) containing RAW264.7 macrophages challenged with a combination of Ti particles and Ad-siTNFα-BMP-2 (Ti-ad CM) assessed by alkaline phosphatase activity. The receptor activator of nuclear factor-κB ligand was downregulated in pro-osteoblastic MC3T3-E1 cells treated with Ti-ad CM in comparison with conditioned medium of RAW264.7 macrophages challenged with Ti particles (Ti CM). We suggest that Ad-siTNFα-BMP-2 induced osteoblast differentiation and inhibited osteoclastogenesis on a cell model of a Ti particle-induced inflammatory response, which may provide a novel approach for the treatment of periprosthetic osteolysis.


Asunto(s)
Animales , /metabolismo , Osteoblastos/metabolismo , ARN Interferente Pequeño/metabolismo , Titanio/efectos adversos , Factor de Necrosis Tumoral alfa/metabolismo , Adenoviridae/genética , /genética , Resorción Ósea/genética , Diferenciación Celular , Línea Celular , Expresión Génica , Vectores Genéticos/genética , Osteoblastos/citología , Osteoblastos/efectos de los fármacos , ARN Interferente Pequeño/genética , Factor de Necrosis Tumoral alfa/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA